Loading…

FcγRIIa: A New Cardiovascular Risk Marker

Platelet expression of FcγRIIa reflects megakaryocyte production that is increased by interferon gamma (3). [...]platelet expression of FcγRIIa would be expected to change as a reflection of systemic inflammation and would be less likely to exhibit the substantial intraindividual variability that ha...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2018-07, Vol.72 (2), p.237-238
Main Authors: Schneider, David J., McMahon, Sean R., Chava, Sreedivya, Taatjes-Sommer, Heidi S., Meagher, Sean, Ehle, Gregory L., Brummel-Ziedins, Kathleen E.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 238
container_issue 2
container_start_page 237
container_title Journal of the American College of Cardiology
container_volume 72
creator Schneider, David J.
McMahon, Sean R.
Chava, Sreedivya
Taatjes-Sommer, Heidi S.
Meagher, Sean
Ehle, Gregory L.
Brummel-Ziedins, Kathleen E.
description Platelet expression of FcγRIIa reflects megakaryocyte production that is increased by interferon gamma (3). [...]platelet expression of FcγRIIa would be expected to change as a reflection of systemic inflammation and would be less likely to exhibit the substantial intraindividual variability that has been observed with currently available tests of platelet function (1). [...]platelet FcγRIIa expression provides a tangible link between systemic inflammation and increased platelet reactivity. In summary, we found that increased platelet FcγRIIa expression identifies patients at greater risk of CVE. Because FcγRIIa augments platelet reactivity (2), we propose that platelet FcγRIIa expression is a new marker of increased platelet reactivity capable of identifying patients at increased risk of CVE and that platelet FcγRIIa expression is likely to be a more consistent marker of increased platelet reactivity over time.
doi_str_mv 10.1016/j.jacc.2018.04.046
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2066475378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S073510971834720X</els_id><sourcerecordid>2066475378</sourcerecordid><originalsourceid>FETCH-LOGICAL-e292t-ff393c2192678e3f6842bab8207a27e2a3501ecf4a49c04eb0919a07f1c1d9963</originalsourceid><addsrcrecordid>eNpdkNFKwzAUhoMobk5fwAspeCNC60nSJo14M4bTwVQYeh3S9BTadetM1onP5Xv4TLZMb4Qfzs3Hz38-Qs4pRBSouKmiylgbMaBpBHEXcUCGNEnSkCdKHpIhSJ6EFJQckBPvKwAQKVXHZMCUkoIpOSTXU_v9tZjNzG0wDp7xI5gYl5fNznjb1sYFi9IvgyfjluhOyVFhao9nv3dE3qb3r5PHcP7yMJuM5yEyxbZhUXDFLaOKCZkiL0Qas8xkKQNpmERmeAIUbRGbWFmIMQNFlQFZUEtzpQQfkat978Y17y36rV6V3mJdmzU2rdcMhIhlwmXaoZf_0Kpp3bpb11O8GwFpX3jxS7XZCnO9ceXKuE_9Z6ED7vYAdm_tSnTa2xLXFvPSod3qvCk1Bd1L15Xupeteuoa4i-A_xDVw5Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2063219086</pqid></control><display><type>article</type><title>FcγRIIa: A New Cardiovascular Risk Marker</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Schneider, David J. ; McMahon, Sean R. ; Chava, Sreedivya ; Taatjes-Sommer, Heidi S. ; Meagher, Sean ; Ehle, Gregory L. ; Brummel-Ziedins, Kathleen E.</creator><creatorcontrib>Schneider, David J. ; McMahon, Sean R. ; Chava, Sreedivya ; Taatjes-Sommer, Heidi S. ; Meagher, Sean ; Ehle, Gregory L. ; Brummel-Ziedins, Kathleen E.</creatorcontrib><description>Platelet expression of FcγRIIa reflects megakaryocyte production that is increased by interferon gamma (3). [...]platelet expression of FcγRIIa would be expected to change as a reflection of systemic inflammation and would be less likely to exhibit the substantial intraindividual variability that has been observed with currently available tests of platelet function (1). [...]platelet FcγRIIa expression provides a tangible link between systemic inflammation and increased platelet reactivity. In summary, we found that increased platelet FcγRIIa expression identifies patients at greater risk of CVE. Because FcγRIIa augments platelet reactivity (2), we propose that platelet FcγRIIa expression is a new marker of increased platelet reactivity capable of identifying patients at increased risk of CVE and that platelet FcγRIIa expression is likely to be a more consistent marker of increased platelet reactivity over time.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2018.04.046</identifier><identifier>PMID: 29976297</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Cardiology ; Diabetes ; Patients</subject><ispartof>Journal of the American College of Cardiology, 2018-07, Vol.72 (2), p.237-238</ispartof><rights>2018 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Jul 10, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29976297$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schneider, David J.</creatorcontrib><creatorcontrib>McMahon, Sean R.</creatorcontrib><creatorcontrib>Chava, Sreedivya</creatorcontrib><creatorcontrib>Taatjes-Sommer, Heidi S.</creatorcontrib><creatorcontrib>Meagher, Sean</creatorcontrib><creatorcontrib>Ehle, Gregory L.</creatorcontrib><creatorcontrib>Brummel-Ziedins, Kathleen E.</creatorcontrib><title>FcγRIIa: A New Cardiovascular Risk Marker</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>Platelet expression of FcγRIIa reflects megakaryocyte production that is increased by interferon gamma (3). [...]platelet expression of FcγRIIa would be expected to change as a reflection of systemic inflammation and would be less likely to exhibit the substantial intraindividual variability that has been observed with currently available tests of platelet function (1). [...]platelet FcγRIIa expression provides a tangible link between systemic inflammation and increased platelet reactivity. In summary, we found that increased platelet FcγRIIa expression identifies patients at greater risk of CVE. Because FcγRIIa augments platelet reactivity (2), we propose that platelet FcγRIIa expression is a new marker of increased platelet reactivity capable of identifying patients at increased risk of CVE and that platelet FcγRIIa expression is likely to be a more consistent marker of increased platelet reactivity over time.</description><subject>Cardiology</subject><subject>Diabetes</subject><subject>Patients</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkNFKwzAUhoMobk5fwAspeCNC60nSJo14M4bTwVQYeh3S9BTadetM1onP5Xv4TLZMb4Qfzs3Hz38-Qs4pRBSouKmiylgbMaBpBHEXcUCGNEnSkCdKHpIhSJ6EFJQckBPvKwAQKVXHZMCUkoIpOSTXU_v9tZjNzG0wDp7xI5gYl5fNznjb1sYFi9IvgyfjluhOyVFhao9nv3dE3qb3r5PHcP7yMJuM5yEyxbZhUXDFLaOKCZkiL0Qas8xkKQNpmERmeAIUbRGbWFmIMQNFlQFZUEtzpQQfkat978Y17y36rV6V3mJdmzU2rdcMhIhlwmXaoZf_0Kpp3bpb11O8GwFpX3jxS7XZCnO9ceXKuE_9Z6ED7vYAdm_tSnTa2xLXFvPSod3qvCk1Bd1L15Xupeteuoa4i-A_xDVw5Q</recordid><startdate>20180710</startdate><enddate>20180710</enddate><creator>Schneider, David J.</creator><creator>McMahon, Sean R.</creator><creator>Chava, Sreedivya</creator><creator>Taatjes-Sommer, Heidi S.</creator><creator>Meagher, Sean</creator><creator>Ehle, Gregory L.</creator><creator>Brummel-Ziedins, Kathleen E.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20180710</creationdate><title>FcγRIIa: A New Cardiovascular Risk Marker</title><author>Schneider, David J. ; McMahon, Sean R. ; Chava, Sreedivya ; Taatjes-Sommer, Heidi S. ; Meagher, Sean ; Ehle, Gregory L. ; Brummel-Ziedins, Kathleen E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e292t-ff393c2192678e3f6842bab8207a27e2a3501ecf4a49c04eb0919a07f1c1d9963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Cardiology</topic><topic>Diabetes</topic><topic>Patients</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schneider, David J.</creatorcontrib><creatorcontrib>McMahon, Sean R.</creatorcontrib><creatorcontrib>Chava, Sreedivya</creatorcontrib><creatorcontrib>Taatjes-Sommer, Heidi S.</creatorcontrib><creatorcontrib>Meagher, Sean</creatorcontrib><creatorcontrib>Ehle, Gregory L.</creatorcontrib><creatorcontrib>Brummel-Ziedins, Kathleen E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schneider, David J.</au><au>McMahon, Sean R.</au><au>Chava, Sreedivya</au><au>Taatjes-Sommer, Heidi S.</au><au>Meagher, Sean</au><au>Ehle, Gregory L.</au><au>Brummel-Ziedins, Kathleen E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FcγRIIa: A New Cardiovascular Risk Marker</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2018-07-10</date><risdate>2018</risdate><volume>72</volume><issue>2</issue><spage>237</spage><epage>238</epage><pages>237-238</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Platelet expression of FcγRIIa reflects megakaryocyte production that is increased by interferon gamma (3). [...]platelet expression of FcγRIIa would be expected to change as a reflection of systemic inflammation and would be less likely to exhibit the substantial intraindividual variability that has been observed with currently available tests of platelet function (1). [...]platelet FcγRIIa expression provides a tangible link between systemic inflammation and increased platelet reactivity. In summary, we found that increased platelet FcγRIIa expression identifies patients at greater risk of CVE. Because FcγRIIa augments platelet reactivity (2), we propose that platelet FcγRIIa expression is a new marker of increased platelet reactivity capable of identifying patients at increased risk of CVE and that platelet FcγRIIa expression is likely to be a more consistent marker of increased platelet reactivity over time.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29976297</pmid><doi>10.1016/j.jacc.2018.04.046</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2018-07, Vol.72 (2), p.237-238
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_miscellaneous_2066475378
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Cardiology
Diabetes
Patients
title FcγRIIa: A New Cardiovascular Risk Marker
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A03%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fc%CE%B3RIIa:%20A%20New%20Cardiovascular%20Risk%20Marker&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Schneider,%20David%20J.&rft.date=2018-07-10&rft.volume=72&rft.issue=2&rft.spage=237&rft.epage=238&rft.pages=237-238&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2018.04.046&rft_dat=%3Cproquest_pubme%3E2066475378%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e292t-ff393c2192678e3f6842bab8207a27e2a3501ecf4a49c04eb0919a07f1c1d9963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2063219086&rft_id=info:pmid/29976297&rfr_iscdi=true